Pharmaceutical Industry News
Analysis of regulation, quality, innovation, market and trends in Europe and Latin America.
Anvisa: New Measures to Ban Cosmetics used in Injectable Form
Anvisa has published two resolutions suspending the trade, distribution, manufacture and use of products from the companies PHD Cosméticos and Biometik, due...
Anvisa Regulates the Import of Regularized Medical Devices
It is now possible to import medical devices that were manufactured abroad before the date of their regularization in Brazil, as long...
Cofepris – New Regulatory Safety Strategy for Medical Devices
Cofepris has launched a Regulatory Safety Strategy for medical devices, aimed at strengthening regulation and collaboration with companies in a market worth...
Anvisa – Changes in RDC 821/2023 and IN 258/2023
Anvisa informs that RDC 821/2023 and IN 258/2023 come into force November 1, simplifying the qualification of impurities in pharmaceutical products....
RDC 653: Changes to the transportation and storage of medicines
RDC 653 introduces important corrections to the management of temperature control of goods and the period of application of the rules....
Anvisa warns about aesthetic products used in injectable form
Anvisa warns that aesthetic products intended for injectable procedures cannot be regulated as cosmetics....
Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.
Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.
Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.
Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.